PMA supplement

P110021 S030: EDWARDS SAPIEN TRANSCATHETER HEART VALVE AND TRANSFEMORAL AND TRANSAPICAL ACCESSORIES

FDA PMA supplement · Special (Immediate Track) · Edwards Lifesciences, LLC

Key facts

Original PMA P110021
Supplement number S030
Supplement type Special (Immediate Track)
Reason for the supplement Labeling Change - Indications/instructions/shelf life/tradename
Trade name EDWARDS SAPIEN TRANSCATHETER HEART VALVE AND TRANSFEMORAL AND TRANSAPICAL ACCESSORIES
Generic name Aortic valve, prosthesis, percutaneously delivered
Applicant Edwards Lifesciences, LLC
Product code NPT
Received date Oct 22, 2013
Decision date Nov 18, 2013

At a glance

  • No Expedited review granted
  • No Approval order on file
  • No Summary of safety and effectiveness on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA supplements

A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA supplements